|
Establishment
|
：
|
September
27, 1997 |
|
Location
|
：
|
KSP West
3F, Sakado 3-2-1 Kanagawa, Japan |
| Phone: 8144-819-2013,
Fax: 8144-819-2014 |
| mailto:
info@netech.jp |
| Raised Capital
|
：
|
JPY318MM
(about US$2.6MM) |
|
Employees
|
：
|
８ |
|
Stock Holders
|
：
|
Venture Capitals |
| Material manufacturers |
| KSP (Kanagawa Science
Park) |
| Hirofumi Yura, etc. |
| |
|
Management Team
|
：
|
CEO |
Hirofumi
Yura |
|
|
| Directors |
Masanori Fujii |
|
|
| |
Shigeo Iino |
|
|
| |
Norihito Shiraishi |
|
|
| Auditor |
Shogo Yasue |
|
|
| |
| NeTech, Inc. is a technology
based venture company established in 1997. NeTech's core technology
was derived from the research result of a publicly supported program
of Kanagawa Prefecture and its proprietary rights reside in syntheses
and modification of sugar related compounds to obtain biologically
functional sugar derivatives. In principle, they are glyco-conjugates
synthesized/modified starting from natural carbohydrates. NeTech has
three groups of compounds which are presently under development for
commercialization. They are: |
|
|
|
(1)
|
Photo-reactive
chitosan (PRC), |
|
(2)
|
Reconstructed
glycosaminoglycan (GAG), |
|
(3)
|
Reconstructed
galactose. |
| |
| Compounds in these groups have different
biological functions and thus provide unique and interesting applications
respectively. Photo-reactive chitosan is expected to function as medical
adhesives and wound dressing due to solidification and adhesion on
the surface of tissues on photo-irradiation. Reconstructed glycosaminoglycans
involve in regulatory effects of cell proliferation to offer anti-cancer
activity and neointimal hyperplasia inhibition. Reconstructed galactose
allows blood cells to bind to solid support immobilized with it via
the affinity of galactose-specific lectin, and is to be utilized for
cell diagnosis based on selective separation of blood cells expressing
galactose differently. |
| |
Biological functions known to sugar compounds
may be categorized as below.
1) Cell recognition including biochemical binding of hormones
and toxins, viral and bacterial infection, antiinflammation
and cell growth control,
2) Energy storage,
3) Modification such as glucuronide conjugation,
4) Lubrication of joints, and
5) Structural material to support cell skeleton.
Recognition reactions involve relatively short chain of sugars,
while physical functions require longer chain of polysaccharides.
Proprietary technology of NeTech resides on this platform and
NeTech offers functional sugar compounds for easy uses. Materials
under development by NeTech include shorter-chain compounds
for recognition reaction and long-chain polysaccharides for
tissue compatibility with high functionality. They are chemically
stable and homogeneous. Reconstructed sugar compounds, PV-sugars,
are being distributed through Seikagaku Corporation as research
reagents. |
|
| |
|
|
|
